Revvity Inc (BSP:R1VT34)
R$ 23.77 0 (0%) Market Cap: 81.00 Bil Enterprise Value: 93.46 Bil PE Ratio: 56.19 PB Ratio: 1.79 GF Score: 65/100

PerkinElmer Inc at Barclays Global Healthcare Conference (Virtual) Transcript

Mar 10, 2021 / 02:45PM GMT
Release Date Price: R$24.39 (-6.21%)
Luke England Sergott
Barclays Bank PLC, Research Division - Research Analyst

All right. I think we're ready to go. Good morning, everybody, Luke Sergott from Barclays. I cover life science tools and diagnostics here. It is my great pleasure to introduce Prahlad Singh from PerkinElmer. He had taken over during an easy time to take over a company right ahead of a pandemic. So with that, if you want to provide some -- a quick couple sentences background and overview, and then we can just dive right into questions, if that works for you.

Prahlad R. Singh
PerkinElmer, Inc. - CEO, President & Director

Sounds good. Good morning. Thank you, Luke, for the opportunity. It's been an interesting 14 months now. When we began the year, obviously, our focus was we have put a lot of effort in reorganizing the company, combining our commercial teams, uniting -- unifying R&D and bringing it together, both the erstwhile DAS and DX segments from a commercial and a technology perspective. And going into 2020, we were very excited about the progress we would make. But

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot